"Serotonin and depression: A disconnect between the advertisements and the scientific literature."
"Some 19 million people in the U.S. suffer from depression in any given year. For many, SSRIs help little, if at all. To do better, we have to get the science right." Sharon Begley, Wall Street Journal
Dr. Scott Gottlieb’s ties to drug firms spark questions over agency hiring policies
An Epidemic of Overreaction /The scare Scenario / The Fear Epidemic Thu, 27 Oct 2005 Dr. Marc Siegel, a practicing internist and an associate professor of medicine at New York University School of Medicine, and a subscriber to the AHRP Infomails, forwarded 3 recent Op Ed articles he has published–in…
TeenScreen: the Law Suits Begin Mon, 13 Jun 2005 Newsworthy developments about the duo-drug promotion scam‹TeenScreen & TMAP: A. The first legal challenge against TeenScreen, the mental health screening scheme that is invading the public school system across the nation, declaring otherwise normal children to be mentally ill, has been…
The Power of $4 bill Drug Ads: Doctors Respond with Diagnosis & Prescription – WashPost Thu, 28 Apr 2005 What does $4 billion dollars in drug advertising buy? The Washington Post reports that a University of Washington study published in the Journal of the American Medical Association confirms the insidious…
Despite Accutane Suicide Risk, Judge Refuses to make company Memos Public Mon, 31 Jan 2005 Judge James Moody, A federal judge in Tampa, Florida, ruled against plaintiff lawyers who sought to share internal documents belonging to Hoffman-LaRoche that show the company knew about the increased suicide risk associated with the…
TeenScreen – Angel of Mercy or Pill-Pusher for Drug Industry Thu, 14 Apr 2005 An investigative reporter has dug up the facts behind TeenScreen, the aggressive marketing scheme that targets America’s school children who are being “screened” for undetected mental problems – even though no accurate diagnostic screening tool for…
TIME – Medicating Young Minds with Mood / Behavior Altering Drugs Sat, 1 Nov 2003 A TIME magazine cover story (excerpt below) looks at the inordinate popularity of prescribing mood altering psychotropic drugs for children begins to raise troubling questions about the specter of doing long-term harm to children. Doctors…
Gene Therapy Experiment Called “Crazy” Tue, 19 Aug 2003 The New York Times reports about yet another example of the ‘Cowboy’ approach to medical research. Doctors who founded Neurologix, a private company that is paying for New York-Presbyterian Hospital to test the safety of a radical experimental approach to treat…
Fast for Freedom: A debate (of sorts) about scientific evidence Sat, 23 Aug 2003 The Medical Director of the APA was unable to cite a single scientific study proving an underlying biochemical basis for any mental illness. An amazing exchange between Dr. James Scully and a panel of experts lays…
Debate Over Antidepressants – Letters NYT Mon, 11 Aug 2003 The New York Times published 5 letters re: “Debate Resumes on the Safety of Depression’s Wonder Drugs.” One letter from someone who experienced “a minor depressive episode” and was prescribed Celexa, one of the SSRI antidepressants. He describes experiencing “extreme,…
AHRP Letter to the editor re: editorial ARDS trial July 10, 2003. The New England Journal of Medicine. Volume 349:188-192 Number 2 http://content.nejm.org/cgi/content/extract/349/2/188 Note: The April 3, 2003 the NEJM contained an editorial in support of a controversial multi-site, clinical trial sponsored by the National Heart, Lung, and Blood Institute…
